The Use of IgG Antibody Avidity Assays in the Diagnosis of Cytomegalovirus Infection
Authors:
V. Štěpánová 1; L. Plíšková 2; M. Kubišová 3; E. Štěpánová 4; R. Bolehovská 2; V. Boštíková 5; M. Svobodová 6
Authors‘ workplace:
Ústav klinické mikrobiologie, NRL pro CMV, FN a LF UK Hradec Králové
1; Ústav klinické biochemie a diagnostiky, FN a LF UK Hradec Králové
2; Gerontometabolická klinika, 2. interní klinika, FN a LF UK, Hradec Králové
3; 2. interní klinika FN a LF UK, Hradec Králové
4; Katedra epidemiologie a mikrobiologie Fakulty vojenského zdravotnictví Univerzity obrany, Hradec Králové
5; Oddělení klinické mikrobiologie Nemocnice Pardubice
6
Published in:
Epidemiol. Mikrobiol. Imunol. 60, 2011, č. 3, s. 115-120
Overview
Human cytomegalovirus (CMV) is the most common cause of congenital infection. Primary CMV infection can lead to severe disease and complications in patients immunocompromised as a result of disease or therapy. IgG antibody avidity assays make it possible to differentiate between primary infection and reactivation of latent infection or reinfection. The study objective was to determine CMV IgG avidity by enzyme-linked immunosorbent assay (ELISA) with denaturation of IgG antibody binding to the antigen and by chemiluminiscent microparticle immunoassay (CMIA) on an Abbott Architect analyzer.
Both methods yielded comparable CMV IgG avidity results. In some cases, the Abbott test was superior in reflecting IgG antibody maturation during primary infection to microplate ELISA using antigen-antibody complex dissociation by a denaturing agent.
Key words:
cytomegalovirus (CMV) – IgG antibodies – avidity – primary infection
Sources
1. Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M., Britt, W. J. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. The New Engl. J. Med., 2001, 344, 18, p. 1366–1371.
2. Curdt, I., Praast, G., Sickinger, E., Schultess, J., Herold, I. et al. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. J. Clin. Microbiol., 2009, 47, 3, p. 603–613.
3. De Paschale, M., Agrappi, C., Manco, M. T., Paganini, A., Clerici, P. Incidence and risk of cytomegalovirus infection during pregnancy in an urban area of Northern Italy. Infect. Dis. Obstet. Gynecol., 2009, Epub 2009 Jul 26.
4. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J., Alford, C. A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. The New Engl. J. Med., 1992, 326, 10, p. 663–667.
5. Fowler, K. B., McCollister, F. P. E., Dahle, A. J. P., Boppana, S. B., Britt, W. J. M. D., Pass, R. F. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J. Pediat., 1997, 130, p. 624–630.
6. Fowler, K. B., Stagno, S., Pass, R. F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA, 2003, 289, 8, p. 1008–1011.
7. Gentile, M., Galli, C., Pagnotti, P., Di Marco, P., Tzantzoglou, S. et al. Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy. Eur. J. Clin. Microbiol. Infect. Dis., 2009, 28, 8, p. 977–9781.
8. Grangeot-Keros, L., Mayaux, M. J., Lebon, P., Freymuth, F., Eugene, G. et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis., 1997, 175, p. 944–946.
9. Griswold, W. R. A Quantitative Relationship Between Antibody Affinity and Antibody Avidity. Immunol. Investigations, 1987, 16, 2, p. 97–106.
10. Guerra, B., Lazzarotto, T., Quarta, S., Lanari, M. et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am. J. Obstet. Gynecol., 2000, 183, p. 476–482.
11. Huzly, D., Neumann-Haefelin Measurement of CMV IgG avidity improves the diagnosis of congenital CMV infection. Eurovirology 2007, Evropský virologický kongres, Norimberk.
12. Krejsek, J., Kopecký, O. B lymfocyty a protilátková imunita. In Klinická imunologie. Nucleus: Hradec Králové 2004, s. 241–270.
13. Lagrou, K., Bodeus M., Van Ranst M., Goubau P. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J. Clin. Microbiol., 2009, 47, 6, p. 1695–1699.
14. Lazzarotto, T., Guerra, B., Lanari, M., Gabrielli, L., Landini, M. P. New advances in the diagnosis of congenital cytomegalovirus infection. J. Clin. Virol., 2008, 41, 3, p. 92–97.
15. Munro, S. C., Hall, B., Whybin, L. R., Leader, L., Robertson, P. et al. Diagnosis of and Screening for Cytomegalovirus Infection in Pregnant Women. J. Clin. Microbiol., 2005, 43, 9, p. 4713–4718.
16. Picone, O., Vauloup-Fellous, C., Cordier, A. G., Parent Du ChČtelet, I., Senat, M. V. et al. 2-year study on cytomegalovirus infection during pregnancy in a French hospital. Internat. J. Obstetr. Gynaecol., 2009, 116, 6, p. 818–823.
17. Revello, M. G., Gerna, G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev., 2002, 15, p. 680–715.
18. Sickinger, E., Gay-Andrieu, F., Jonas, G., Schultess, J., Stieler, M. et al. Performance characteristics of the new Architect Toxo IgG and Toxo IgG Avidity assay. Diagn. Microbiol. Infectious. Dis., 2008, 62, p. 235–244.
19. Special Instruction for Architect CMV IgG Avidity Assay. Příbalový leták. Abbott Diagnostics Division 2007.
20. Stagno, S., Pass, R. F., Dworsky, M. E. Congenital cytomegalovirus infection. The relative importance of primary and recurrent maternal infection. The New Engl. J. Med., 1982, 306, 16, p. 945–949.
21. Stagno, S., Whitley, R. J. Herpesvirus infections of pregnancy – part I: cytomegalovirus and Epstein-Barr virus infections. The New Engl. J. Med., 1985, 313, 20, p. 1270–1274.
22. Staras, S. A., Flanders, W. D., Dollard, S. C., Pass, R. F., McGowan, J. E. Jr., Cannon, M. J. Cytomegalovirus seroprevalence and childhood sources of infection:A population-based study among preadolescents in the United States. J. Clin. Virol., 2008, 43, 3, p. 266–271.
Labels
Hygiene and epidemiology Medical virology Clinical microbiologyArticle was published in
Epidemiology, Microbiology, Immunology
2011 Issue 3
Most read in this issue
- The Use of IgG Antibody Avidity Assays in the Diagnosis of Cytomegalovirus Infection
- Amoebae of the Genus Acanthamoeba – Causative Agents of Human Infections
- Vaccination against Viral Hepatitis A and B in Adults Aged over 40 Years – Antibody Persistence and Immune Memory
- Prevention of Tick-Borne Meningoencephalitis – Summary Report